PF-08046054: clinical trials recruiting now

Fewer than 3 recruiting trials found.

2

Recruiting trials

14

Conditions studied

32

US states with sites

29

Countries

Phase breakdown

Phase 1 1 Phase 3 1

Conditions being studied

Condition	Trials
Lung cancer	2
Breast cancer	1
Carcinoma, Non-Small-Cell Lung	1
Endometrial Cancer	1
Esophageal Squamous Cell Carcinoma	1
Gastric Cancer	1
Hepatocellular Carcinoma	1
Non-Small Cell Lung Cancer Metastatic	1
Non-Small Cell Lung Carcinoma	1
Non-small Cell Carcinoma	1
Pancreatic Adenocarcinoma	1
Pancreatic cancer	1
Squamous Cell Carcinoma of the Head and Neck	1
Triple Negative Breast Neoplasms	1

Recruiting trials involving PF-08046054

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
NCT05208762 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 62 locations
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
NCT07144280 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 431 locations

Common questions

How many recruiting trials involve PF-08046054?

2 recruiting trials across 14 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.